Last reviewed · How we verify

NCT05184244

Turkish Adaptation of the Activity Limitations in Cerebral Palsy Questionnaire

Completed Last updated 25 January 2022
What this trial tests

trial testing Activity Limitation Assessment in Activity, Motor in 89 participants. Completed in 1 November 2021.

Timeline
1 December 2020
Primary endpoint
1 September 2021
1 November 2021

Quick facts

Lead sponsorIzmir Katip Celebi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment89
Start date1 December 2020
Primary completion1 September 2021
Estimated completion1 November 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir Katip Celebi University

Who can join

Adults 2 to 18, any sex, with Activity, Motor or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to make the Turkish adaptation of ACTIVLIM-CP and to examine its psychometric properties. Eighty-nine individuals with CP, aged between 2-18 years were included in the study. PEDİ, ABILOCO-Kids, and ABILHAND-Kids scores and Wee-FIM questionnaires were used for validity analysis. Test re-test method was used for reliability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Activity, Motor

Currently open trials in the same condition.

Other Izmir Katip Celebi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05184244.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing